Cargando…
P213 Lasiodiplodia theobromae: an emerging human pathogen
POSTER SESSION 2, SEPTEMBER 22, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Lasiodiplodia theobromae is a dematiaceous fungus, rarely reported to cause infections in humans. This case-series was conducted to identify the potential risk-factors and spectrum of diseases caused by L. theobromae. METHODS: W...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509726/ http://dx.doi.org/10.1093/mmy/myac072.P213 |
_version_ | 1784797290709385216 |
---|---|
author | Kanaujia, Rimjhim Gupta, Sunita Kaur, Harsimran Kindo, Anupama J. Shetty, Anjali Marak, Rungmei Rammohan, Ram Singla, Nidhi Capoor, Malini Balajee, G. Gopal, Lokeshwari Rastogi, Vijaylatha Karuna, Tadepalli Hemashettar, Basavaraj Harkuni, Sheetal M., Shivaprakash Rudramurthy |
author_facet | Kanaujia, Rimjhim Gupta, Sunita Kaur, Harsimran Kindo, Anupama J. Shetty, Anjali Marak, Rungmei Rammohan, Ram Singla, Nidhi Capoor, Malini Balajee, G. Gopal, Lokeshwari Rastogi, Vijaylatha Karuna, Tadepalli Hemashettar, Basavaraj Harkuni, Sheetal M., Shivaprakash Rudramurthy |
author_sort | Kanaujia, Rimjhim |
collection | PubMed |
description | POSTER SESSION 2, SEPTEMBER 22, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Lasiodiplodia theobromae is a dematiaceous fungus, rarely reported to cause infections in humans. This case-series was conducted to identify the potential risk-factors and spectrum of diseases caused by L. theobromae. METHODS: We performed a retrospective analysis of all cases from which the isolates of the L. theobromae were accessioned at the National culture collection of pathogenic fungi (NCCPF), over the last 10 years (January 2012- March 2022). The isolates were retrieved and identified by conventional (colony morphology, color, and microscopic appearances) and molecular (sequencing of ITS1 region of ribosomal DNA) methods. In vitro antifungal susceptibility testing (AFST) was performed by microbroth dilution recommended by the Clinical and Laboratory Standards Institute (CLSI). (M38-A2). The clinical features, demographic details and outcome were recorded. RESULTS: In 10 years, a total of 20 patients were identified. The median age of all cases was 39.5 (range: 13-71 years) and 75% were males. The most common clinical presentation was keratomycosis (12,68.6%), followed by soft tissue/sub-cutaneous infection (3,15%), rhinosinusitis (3,15%), onychomycosis (1, 5%), and pneumonia (1, 5%). Most patients were immunocompetent (85%). Among immunocompromised, two patients had acute myeloid leukemia and developed fungal rhinosinusitis while one patient of post-renal transplant on immunosuppressants developed subcutaneous tissue infection in the interscapular region. The fourth patient had decompensated alcoholic hepatitis, encephalopathy, sepsis, and developed pneumonia while he was on mechanical ventilation. Among the various potential risk factors associated with keratomycosis, the most common were, accidental trauma wounds (9, 45%), and mosquito bite in the eye in one patient. The culture on Sabouraud's dextrose agar (SDA) revealed the growth of black mycelial fungus (Fig. 1a). The lactophenol cotton blue (LCB) mount revealed the presence of only dematiaceous septate hyphae which failed to sporulate (Fig. 1b). All the isolates were confirmed by sequencing of ITS (internal transcribed spacer) region of the rDNA using universal primers ITS1 and ITS2. In vitro antifungal susceptibility testing (AFST) was performed using a broth microdilution (BMD) method which revealed variable MIC (μg/ml), i.e., amphotericin (1-2), voriconazole (0.25-2), itraconazole (8-16), posaconazole (1-2). All patients improved on therapy except one patient who succumbed to death due to pneumonia. CONCLUSION: Lasiodiplodia theobromae is an emerging cause of human infections in both immunocompetent and immunosuppressed individuals. It is often difficult to identify due to lack of sporulation making morphological identification challenging. Hence, prompt suspicion and rapid diagnosis with guided therapy are necessary for a better outcome. |
format | Online Article Text |
id | pubmed-9509726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95097262022-09-26 P213 Lasiodiplodia theobromae: an emerging human pathogen Kanaujia, Rimjhim Gupta, Sunita Kaur, Harsimran Kindo, Anupama J. Shetty, Anjali Marak, Rungmei Rammohan, Ram Singla, Nidhi Capoor, Malini Balajee, G. Gopal, Lokeshwari Rastogi, Vijaylatha Karuna, Tadepalli Hemashettar, Basavaraj Harkuni, Sheetal M., Shivaprakash Rudramurthy Med Mycol Oral Presentations POSTER SESSION 2, SEPTEMBER 22, 2022, 12:30 PM - 1:30 PM: OBJECTIVES: Lasiodiplodia theobromae is a dematiaceous fungus, rarely reported to cause infections in humans. This case-series was conducted to identify the potential risk-factors and spectrum of diseases caused by L. theobromae. METHODS: We performed a retrospective analysis of all cases from which the isolates of the L. theobromae were accessioned at the National culture collection of pathogenic fungi (NCCPF), over the last 10 years (January 2012- March 2022). The isolates were retrieved and identified by conventional (colony morphology, color, and microscopic appearances) and molecular (sequencing of ITS1 region of ribosomal DNA) methods. In vitro antifungal susceptibility testing (AFST) was performed by microbroth dilution recommended by the Clinical and Laboratory Standards Institute (CLSI). (M38-A2). The clinical features, demographic details and outcome were recorded. RESULTS: In 10 years, a total of 20 patients were identified. The median age of all cases was 39.5 (range: 13-71 years) and 75% were males. The most common clinical presentation was keratomycosis (12,68.6%), followed by soft tissue/sub-cutaneous infection (3,15%), rhinosinusitis (3,15%), onychomycosis (1, 5%), and pneumonia (1, 5%). Most patients were immunocompetent (85%). Among immunocompromised, two patients had acute myeloid leukemia and developed fungal rhinosinusitis while one patient of post-renal transplant on immunosuppressants developed subcutaneous tissue infection in the interscapular region. The fourth patient had decompensated alcoholic hepatitis, encephalopathy, sepsis, and developed pneumonia while he was on mechanical ventilation. Among the various potential risk factors associated with keratomycosis, the most common were, accidental trauma wounds (9, 45%), and mosquito bite in the eye in one patient. The culture on Sabouraud's dextrose agar (SDA) revealed the growth of black mycelial fungus (Fig. 1a). The lactophenol cotton blue (LCB) mount revealed the presence of only dematiaceous septate hyphae which failed to sporulate (Fig. 1b). All the isolates were confirmed by sequencing of ITS (internal transcribed spacer) region of the rDNA using universal primers ITS1 and ITS2. In vitro antifungal susceptibility testing (AFST) was performed using a broth microdilution (BMD) method which revealed variable MIC (μg/ml), i.e., amphotericin (1-2), voriconazole (0.25-2), itraconazole (8-16), posaconazole (1-2). All patients improved on therapy except one patient who succumbed to death due to pneumonia. CONCLUSION: Lasiodiplodia theobromae is an emerging cause of human infections in both immunocompetent and immunosuppressed individuals. It is often difficult to identify due to lack of sporulation making morphological identification challenging. Hence, prompt suspicion and rapid diagnosis with guided therapy are necessary for a better outcome. Oxford University Press 2022-09-20 /pmc/articles/PMC9509726/ http://dx.doi.org/10.1093/mmy/myac072.P213 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of The International Society for Human and Animal Mycology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Oral Presentations Kanaujia, Rimjhim Gupta, Sunita Kaur, Harsimran Kindo, Anupama J. Shetty, Anjali Marak, Rungmei Rammohan, Ram Singla, Nidhi Capoor, Malini Balajee, G. Gopal, Lokeshwari Rastogi, Vijaylatha Karuna, Tadepalli Hemashettar, Basavaraj Harkuni, Sheetal M., Shivaprakash Rudramurthy P213 Lasiodiplodia theobromae: an emerging human pathogen |
title | P213 Lasiodiplodia theobromae: an emerging human pathogen |
title_full | P213 Lasiodiplodia theobromae: an emerging human pathogen |
title_fullStr | P213 Lasiodiplodia theobromae: an emerging human pathogen |
title_full_unstemmed | P213 Lasiodiplodia theobromae: an emerging human pathogen |
title_short | P213 Lasiodiplodia theobromae: an emerging human pathogen |
title_sort | p213 lasiodiplodia theobromae: an emerging human pathogen |
topic | Oral Presentations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509726/ http://dx.doi.org/10.1093/mmy/myac072.P213 |
work_keys_str_mv | AT kanaujiarimjhim p213lasiodiplodiatheobromaeanemerginghumanpathogen AT guptasunita p213lasiodiplodiatheobromaeanemerginghumanpathogen AT kaurharsimran p213lasiodiplodiatheobromaeanemerginghumanpathogen AT kindoanupamaj p213lasiodiplodiatheobromaeanemerginghumanpathogen AT shettyanjali p213lasiodiplodiatheobromaeanemerginghumanpathogen AT marakrungmei p213lasiodiplodiatheobromaeanemerginghumanpathogen AT rammohanram p213lasiodiplodiatheobromaeanemerginghumanpathogen AT singlanidhi p213lasiodiplodiatheobromaeanemerginghumanpathogen AT capoormalini p213lasiodiplodiatheobromaeanemerginghumanpathogen AT balajeeg p213lasiodiplodiatheobromaeanemerginghumanpathogen AT gopallokeshwari p213lasiodiplodiatheobromaeanemerginghumanpathogen AT rastogivijaylatha p213lasiodiplodiatheobromaeanemerginghumanpathogen AT karunatadepalli p213lasiodiplodiatheobromaeanemerginghumanpathogen AT hemashettarbasavaraj p213lasiodiplodiatheobromaeanemerginghumanpathogen AT harkunisheetal p213lasiodiplodiatheobromaeanemerginghumanpathogen AT mshivaprakashrudramurthy p213lasiodiplodiatheobromaeanemerginghumanpathogen |